Forgot your password ?

 login: 

  Why you need to be registered

 password: 

 Register 

Current issueArchivesubscribeInstructions to Authors

search by
Google





subscribe on the news  

 

Pay Color Illustration
 


Medline

PubMed, a service of the National Library of Medicine

World Oncology Network

R.E.Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology



Vol. 24, No. 2, 2002 (June)

Content

CHAPERON HSP-60 AS AUTOANTIGEN IN DEVELOPMENT OF DYSHORMONAL BREAST DISEASES

 

O.G. Vigontina1, O.A. Efimenko2, L.F. Yakovenko1, R.G. Kiyamova1, V.V. Filonenko1, I.T. Gout3, N.V. Ros’ 2, N.V. Kosey2, T.F. Tatarchuk2, L.L. Sidorik1,*, G.Kh. Matsuka1

1Institute of Molecular Biology and Genetics, NAS of Ukraine, Kyiv, Ukraine
2Institute of Pediatrics, Obstetrics and Ginecology, AMS of Ukraine, Kyiv, Ukraine
3Ludwig Institute for Cancer Research, London, United Kingdom

Abstract. Recombinant Hsp-60 chaperon was isolated from the lyzate of E.coli cells transformed with plasmid pT-GroESL, purified by gel-filtration and ion exchange chromatography and used as antigen in the study of autoimmune processes in patients with dyshormonal breast diseases (DBD). It has been shown that the sera of 80% of DBD patients were anti-Hsp-60 positive and the level of anti-Hsp-60 antibodies in the sera of DBD patients was significantly higher (p < 0.05) that that in the sera of healthy donors. The highest levels of anti-Hsp-60 antibodies were registered in the sera of the DBD patients with simultaneous cancer processes.

Key Words: chaperon, dyshormonal breast diseases, breast cancer.

Language:  English

[full text]




Copyright (c) MORION 1999-2008

Current issue | Archive | subscribe | Instructions to Authors | E-Mail to webmaster